Nivolumab re-treatment in patients with relapsed/refractory Hodgkin lymphoma: Safety and efficacy outcomes from a phase 1 clinical trial Meeting Abstract


Authors: Ansell, S.; Armand, P.; Timmerman, J.; Shipp, M.; Popa McKiver, M.; Zhu, L.; Lesokhin, A. M.
Abstract Title: Nivolumab re-treatment in patients with relapsed/refractory Hodgkin lymphoma: Safety and efficacy outcomes from a phase 1 clinical trial
Meeting Title: 10th International Symposium on Hodgkin Lymphoma (ISHL 10)
Journal Title: Haematologica
Volume: 101
Issue: Suppl. 5
Meeting Dates: 2016 Oct 22-25
Meeting Location: Cologne, Germany
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2016-10-01
Start Page: 49
Language: English
ACCESSION: WOS:000392549000116
PROVIDER: wos
PMCID: PMC5080844
Notes: Meeting Abstract: P090 -- Source: Wos
MSK Authors
  1. Alexander Meyer Lesokhin
    371 Lesokhin